Market Overview
USA pet healthcare sales are set to climb, with the market expected to reach USD 7.2 billion by 2031, reflecting a compound annual growth rate of 4.82%. Growth will be supported by a more cautious but still health-focused consumer base, as owners prioritise products that deliver clear functional value. With pet population growth slowing and household spending becoming more conservative, healthcare products are benefiting from their stronger link to necessity, prevention and long-term wellbeing compared with more discretionary pet categories.
Dietary supplements will remain the main growth engine. Rising veterinary costs and an ageing pet population are encouraging owners to manage health earlier through products positioned around digestion, urinary care, skin, joints, immunity and general vitality. The category is also becoming more closely aligned with treat formats, as chews, dual-texture products and lickable supplements help address palatability concerns and make daily use easier. This blurring of supplements and treats should support repeat purchasing, particularly where products solve specific health concerns rather than relying on broad wellness claims.
Ingredient-led innovation will become more important as the market becomes crowded. Brands are using functional cues such as collagen, mushrooms, prebiotics, probiotics, postbiotics, fish oils and other familiar wellness ingredients to stand out in a fragmented category. However, the next phase of growth will depend on credibility as much as novelty. Consumers are likely to scrutinise claims more closely, especially as supplement prices face pressure from higher ingredient costs and supply-chain volatility.
E-commerce and social media will continue to shape discovery, but trust will be a growing issue. Online platforms, subscriptions and influencer-led selling give supplement brands faster access to consumers, yet third-party resellers and social commerce storefronts may raise concerns over legitimacy and product quality. In this environment, stronger performers will be those that combine clear health benefits, reliable sourcing, transparent claims and convenient formats, making pet healthcare feel both functional and worth repeating within everyday care routines.
This report presents a detailed analysis of the USA pet healthcare market, offering six years of historical market size data and growth trends, as well as forward-looking estimates through 2031. It explores category-specific and subcategory dynamics, with a sharp focus on developments across product type and distribution channel.
What’s Inside the Report
This report compiles reliable and actionable data on USA pet healthcare market size trends spanning 2021 to 2031. Presented in (USD), it features validated historical values alongside robust forecasts through 2031, with CAGR included for both periods. Market segmentation includes product type and distribution channel. The format is designed to facilitate comparative analysis and pinpoint high-growth opportunities, supporting strategic insight generation and market entry evaluation.
In addition to granular market metrics, the report captures the broader structural shifts that define the industry’s trajectory. Using proprietary analysis and cross-referenced economic indicators, it maps the interaction between innovations, policy, and consumption patterns. This enables strategic foresight into future growth zones, disruption risk, and innovation-led differentiation, especially within product-focused and region-specific segments.
The report also delivers a comprehensive evaluation of market share changes and core brand performance among leading players from 2021 to the most recent period. It reveals competitive dynamics and trends in market concentration, providing granular market share comparisons and trend analyses. This equips users to better understand competitive advantages and challenges, thereby informing differentiated market strategies and investment decisions with robust empirical evidence.
Market Segmentation
The segmentation of the USA pet healthcare market is outlined below:
Product type – e.g., flea and tick prevention products, pet vitamins and supplements, pet wormers, others
Distribution channel – e.g., e-commerce, hypermarkets, supermarkets, warehouse clubs, others
Macroeconomic & Demographic Indicators
Supporting context includes:
Total population
Consumer Price Index (CPI)
Gross Domestic Product (GDP)
Per capita consumption
Consumer spending as a percentage of GDP
These variables enhance understanding of consumption potential and macroeconomic trends affecting the market.
Competitive Landscape: Market Share Analysis
The report provides an overview of market share among leading firms in the pet healthcare sector in USA, reflecting a mix of established brands and emerging competitors. Companies profiled include: Boehringer Ingelheim Auslandsbeteiligungs GmbH, Elanco Animal Health Incorporated, Foodscience Corporation, Health & Happiness Group International Holdings Ltd. (H&H Group), Manna Pro Products, LLC., Nutramax Laboratories Veterinary Sciences, Inc., PetIQ, Inc., The Hartz Mountain Corporation, etc.
This section helps stakeholders evaluate market concentration, identify partnership opportunities, and track shifts in leadership.
Why Choose This Report?
Designed as a concise yet in-depth data snapshot, this publication is tailored for professionals seeking accurate, timely, and actionable quantitative insights. Whether you’re a market entrant, investor, or established player, the report is built to support robust business decisions with confidence.
Request a redacted sample to preview the data structure and presentation quality before purchase.
Deliverables Include
Professionally structured PDF report
Full EXCEL databook with year-by-year figures and multi-dimensional segmentation from 2021 to 2031
Table of Contents
TABLE OF CONTENTS
Market Segmentation
Market Overview
USA Pet Healthcare Market – Product Type Analysis
USA Pet Healthcare Market – Distribution Channel Analysis
Company/Brand Shares Analysis
Boehringer Ingelheim Auslandsbeteiligungs GmbH
Elanco Animal Health Incorporated
Foodscience Corporation
Health & Happiness Group International Holdings Ltd. (H&H Group)
Manna Pro Products, LLC.
…
Macroeconomic Data and Forecast
Research Methodology
Disclaimer
FIGURES AND TABLES
Table USA Pet Healthcare Market 2021-2031
Chart USA Pet Healthcare Market, Net Growth, 2021-2031
Chart USA Pet Healthcare Market, Growth Rates, 2021-2031
Table USA Pet Healthcare Market by Product Type, 2021-2031
Chart USA Pet Healthcare Market by Product Type, CAGR Historic and Forecast, 2021-2031
Chart USA Pet Healthcare Market by Product Type, 2021-2031
Table USA Pet Healthcare Market by Distribution Channel, 2021-2031
Chart USA Pet Healthcare Market by Distribution Channel, CAGR Historic and Forecast, 2021-2031
Chart USA Pet Healthcare Market by Distribution Channel, 2021-2031
Table USA Pet Healthcare Market Share (%), by Companies, 2021-2025
Chart USA Pet Healthcare Market, by Companies, 2025
Table USA Pet Healthcare Market Share (%), by Brands, 2021-2025
Chart USA Pet Healthcare Market, by Brands, 2025
Table USA – Population (Millions) and Forecast
Table USA – Consumer Price Index (CPI) and Forecast
Table USA – Gross Domestic Product and Forecast
Table USA Pet Healthcare Market: Spend as a Proportion of GDP (%)
Table USA Pet Healthcare Market: Consumption per Capita (Population)
Companies Mentioned
The companies featured in this report include:
Boehringer Ingelheim Auslandsbeteiligungs GmbH
Elanco Animal Health Incorporated
Foodscience Corporation
Health & Happiness Group International Holdings Ltd. (H&H Group)
Manna Pro Products, LLC.
Nutramax Laboratories Veterinary Sciences, Inc.
PetIQ, Inc.
The Hartz Mountain Corporation
